Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Hagen TM, Jones DP
MYC-driven cancer cells exhibit enhanced glutamine utilization accompanied by increased expression of key glutaminolysis enzymes, including GLS1/GLS2 and GLUD1 178,179,180
It has not been evaluated by the FDA (or equivalent agencies) for any use and is not intended for clinical, diagnostic, or veterinary applications
Morrow T (2013) Do comparable efficacy & convenient dosing justify Procysbis extremely high price
See our BPC-157 guide and TB-500 guide for complete protocols
Cancer 89 , 376382 (2000)
US$ 27.61
US$ 28.20
US$ 24.19
US$ 24.81
US$ 26.85
US$ 29.06
US$ 20.31
US$ 22.67
